Gan & Lee Pharmaceuticals.
603087
Classement en actions
#3011
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Prix de l'action
$10.03
Capitalisation boursière
$5.99B
Changement (1 jour)
-3.71%
Changement (1 an)
2.30%
Pays
CN
Échange Gan & Lee Pharmaceuticals. (603087)
Catégorie
Healthcare
EPS pour Gan & Lee Pharmaceuticals. (603087)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Gan & Lee Pharmaceuticals., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Gan & Lee Pharmaceuticals. de 2013 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2025 | $0.28 | 93.61% |
| 2024 | $0.14 | 68.04% |
| 2023 | $0.08 | -174.98% |
| 2022 | $-0.11 | -127.75% |
| 2021 | $0.41 | 21.57% |
| 2020 | $0.34 | 12.22% |
| 2019 | $0.30 | 11.04% |
| 2018 | $0.27 | -18.21% |
| 2017 | $0.33 | 50.25% |
| 2016 | $0.22 | 59.66% |
| 2015 | $0.14 | 39.19% |
| 2014 | $0.10 | 35.86% |
| 2013 | $0.07 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| $8.37 | - |
US
|
|
| $6.41 | - |
FR
|
|
| - | - |
JP
|
|
| $3.32 | - |
US
|
|
| - | - |
CH
|
